Mobia Medical, Inc. Common Stock
MOBIАкція
$12.98
Капіталізація—
P/E—
Див. дохідність—
Бета2.73
Графік ціни
Улюблені метрики
Ціна відносно S&P 500 (4 тиж.)6.60%
Загальна оцінка (VGM)98.12
Порівняння з галуззю — Хірургічні та медичні інструменти(141)
| Символ | Оцінка недооціненості | Оцінка зростання | Оцінка моментуму | Ціна |
|---|---|---|---|---|
MOBIMobia Medical, Inc. Common Stock | — | — | A | $12.98 |
| SYKStryker Corporation | C | C | C | $313.68 |
| MMM3M Company | C | F | B | $165.91 |
| BSXBoston Scientific Corp. | C | B | D | $44.46 |
| MDLNMedline Inc. Class A common stock | C | D | D | $36.05 |
| BDXBecton, Dickinson and Co. | B | C | C | $147.77 |
| RMDResMed Inc. | C | B | D | $196.50 |
| DXCMDexCom, Inc. | C | B | C | $69.75 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $340.41 |
| SOLVSolventum Corporation | C | D | C | $75.59 |
| PENPenumbra, Inc. | D | C | C | $316.36 |
Про акцію
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.